Biorthex expands distribution for SpineCor:
This article was originally published in Clinica
Executive Summary
Orthopaedic company Biorthex is to sell its SpineCor corrective brace in Uruguay, Chile and Argentina. The device, which is already sold in the US and 11 other countries, is to correct minor idiopathic scoliosis. The Montreal, Quebec company says that the $1.1 billion global market for devices to treat spinal column diseases is growing by 20-22% annually.